21 July 2020: Original Paper
Efficacy and Safety of Weight Reduction of the Donor in Hepatic Steatosis for Living Donor Liver Transplantation
Jae Hun Chung 1ACDEF , Je Ho Ryu 123A* , Kwang Ho Yang 12A , Byung Hyun Choi 12CD , Youngmok Park 45AB , Tae Beom Lee 12BF , Jae Ryong Shim 12C , Hyo Jung Ko 12F , Sung Hwan Cho 16DEDOI: 10.12659/AOT.923211
Ann Transplant 2020; 25:e923211
Table 1 Clinical characteristics of conventional group and reduction group.
| Conventional group (n=102) | Weight reduction group (n=7) | p-Value | |
|---|---|---|---|
| Sex | M=76/F=26 | M=7 | 0.126 |
| Age | 27.99±9.31 | 32.14±7.31 | 0.251 |
| BW (kg) | 65.77±11.27 | 85.4±8.25 | 0.052 |
| BMI (BMI, kg/m) | 23.13±3.27 | 28.89±2.30 | 0.025 |
| Steatsosis (%) | 6.19±5.68 | 40.71±14.56 | |
| Relation | |||
| Related | 95 | 5 | 0.466 |
| Non-related | 7 | 2 | |
| Sex | M=78/F=24 | M=4/F=3 | 0.252 |
| Age | 51.39±9.94 | 53.86±5.15 | 0.142 |
| CTP | 1.66±0.84 | 1.71±0.95 | 0.862 |
| MELD | 12.71±7.56 | 8.43±4.47 | 0.518 |
| Etiology | |||
| HCC | 69 | 6 | 0.989 |
| Alcoholic LC | 10 | – | |
| Viral LC (B or C) | 16 | 1 | |
| Others | 7 | – | |
| BW – body weight; BMI – body mass index; MELD – Model For End-Stage Liver Disease. CTP – Child-Turcotte-Pugh; HCC – hepatocellular carcinoma; LC – liver cirrhosis. | |||